tiprankstipranks
Clovis Oncology (GB:0A7C)
LSE:0A7C

Clovis Oncology (0A7C) Stock Investors

0 Followers
Based on 694,460 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold GB:0A7C
On average, investors allocate 2.24% of their portfolios to GB:0A7C
The average holding size of this company in investors' portfolios.

Investor Sentiment

Currently, no data available
Please return soon. This page is being updated.
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding 0A7C

1.1%
Last 7
Days
4.8%
Last 30
Days
Percentages indicate the change in the number of portfolios holding GB:0A7C, out of 694,460 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

0A7C Investor Activity

No data currently available
Based on the activity of 12,787 investors who made their portfolios public
The table shows changes in 0A7C in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

0A7C Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Moderna
5.42%
+0.49%
+0.54%
46.92B
Healthcare
General Electric
5.60%
+0.11%
-0.62%
120.36B
Industrials
DraftKings
6.25%
+0.05%
+0.25%
24.67B
Technology
Nikola
5.75%
-0.02%
+2.73%
1.06B
Energy
Blink Charging Co
4.00%
+0.53%
+2.26%
415.45M
Utilities
Twilio
3.09%
-0.20%
-1.37%
11.69B
Technology
Barrick Gold
6.18%
+0.12%
-0.12%
29.04B
Basic Materials
AMC Entertainment
5.88%
-0.14%
-1.78%
6.42B
Consumer Cyclical
Micron
5.54%
+0.71%
+1.90%
68.43B
Technology
Syros Pharmaceuticals
3.68%
-1.17%
-6.04%
62.40M
Healthcare
Based on the activity of 694,460 active portfolios
Open your Smart Portfolio

0A7C Investor Analysis

GB:0A7C investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
20.3%
of GB:0A7C holders
are under 35
Average Segment Performance
Average P/E Ratio-32.17
Beta9.52
Dividend Yield6.50%
GB:0A7C investors between 35–55

Between 35–55

2.6%
Last 30 days
Holdings Change
60.8%
of GB:0A7C holders
are between 35–55
Average Segment Performance
Average P/E Ratio-28.15
Beta14.38
Dividend Yield19.88%
GB:0A7C investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
18.9%
of GB:0A7C holders
are over 55
Average Segment Performance
Average P/E Ratio-21.43
Beta5.95
Dividend Yield6.10%
Overview of age group and performance of GB:0A7C stock investors
See who invests in 0A7C according to age group and performance.

FAQ

How many retail Investors hold GB:0A7C?
<0.1% of TipRanks' retail investors hold GB:0A7C in their portfolios.
    What is GB:0A7C Investor Sentiment?
    GB:0A7C’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of GB:0A7C in the last 7 days?
      ▼ 1.1% of TipRanks' retail investors changed their holding of GB:0A7C in the last 7 days.
        What percentage of retail investors changed their holding of GB:0A7C in the last 30 days?
        ▼ 4.8% of TipRanks' retail investors changed their holding of GB:0A7C in the last 30 days.
          What is the average age of retail investors who hold GB:0A7C?
          The average age of GB:0A7C Holders is between 35–55.
            What other stocks have GB:0A7C investors also bought?
            GB:0A7C Investors also bought MRNA, GE, DKNG, NKLA, BLNK, TWLO, GOLD, AMC, MU, SYRS.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ACADACADIA Pharmaceuticals
              ATECAlphatec Holdings
              AZNAstraZeneca
              BIIBBiogen
              BLRXBioline RX Ltd Sponsored ADR
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis